FLASCO

Corporate Members

Diamond Elite

Diamond

Platinum

Gold

Silver



On February 15th FLASCO hosted a free “Living with Metastatic Breast Cancer” luncheon Patient Advocacy Program at the Capitol Building in Tallahassee. This educational program was for people who have this advanced type of cancer and their caregivers. The event featured speakers representing the Mayo Clinic Florida, Florida Cancer Specialists, Tallahassee Memorial Cancer Center, and the Florida Breast Cancer Foundation. The speakers discussed the disease itself, treatment options, patient advocacy, caring for the caregiver, and patient assistance programs. A question-and-answer session followed the formal presentations.

Celeste Phillip, MD, MPH, Florida Surgeon General and Secretary Florida Department of Health, joined us on behalf of Governor Scott, to present the Governor’s Proclamation declaring February 2017 as Metastatic Breast Cancer Awareness Month. Click here to read the Proclamation. We were pleased to also have Representative Lori Berman join the audience.

This event would not have been possible without the generous support of our sponsors and exhibitors. Thank you to our grant providers:Pfizer and Florida Breast Cancer Foundation, Meeting sponsor: NanoString Technologies, and Exhibitors: AstraZeneca and Insys.


Latest News

FDA approves first treatment for rare form of skin cancer

Posted March 26, 2017

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer....

Congratulations to Dr. Sonia Orcutt

Congratulations to Dr. Sonia Orcutt

Posted March 26, 2017

Congratulations to Dr. Sonia Orcutt for being a recipient of a FLASCO Travel Award!  Dr. Orcutt used her grant to attend this year’s Society of Surgical Oncology Annual Cancer Symposium.  Below is what Dr. Orcutt shared about her attendance. “The primary conference for my specialty is the Society of Surgical Oncology Annual Cancer Symposium. Each...

FDA Approves EMD Serono’s Avelumab for Merkel Cell Carcinoma

Posted March 24, 2017

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer....

New NCCN Radiation Therapy Compendium™ Aids in Decision-Making for Patients with Cancer

Posted March 23, 2017

Launched during the NCCN 22nd Annual Conference, the new NCCN Radiation Therapy Compendium™ provides a single access point for radiation therapy recommendations within the NCCN Guidelines®. [FORT WASHINGTON, PA – March 23, 2017] Radiation therapy (RT), either alone or in combination with chemotherapy or surgery, is one of the most common treatment options for people...

Who’s Online

There are no users currently online